Published in Epidemiol Infect on January 01, 2004
A long-lasting measles epidemic in Maroua, Cameroon 2008-2009: mass vaccination as response to the epidemic. J Infect Dis (2011) 1.45
Trends of rubella incidence during a 5-year period of case based surveillance in Zimbabwe. BMC Public Health (2015) 0.98
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Deaths and injuries caused by land mines in Mozambique. Lancet (1995) 3.57
Public-health impact of accelerated measles control in the WHO African Region 2000-03. Lancet (2005) 3.36
Measles virus P gene codes for two proteins. J Virol (1985) 3.31
Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology (2000) 2.63
Molecular biology of Hendra and Nipah viruses. Microbes Infect (2001) 2.33
Subacute sclerosing panencephalitis in the differential diagnosis of encephalitis. Neurology (2004) 2.18
Expression of the gene encoding the 17-kilodalton antigen from Rickettsia rickettsii: transcription and posttranslational modification. J Bacteriol (1988) 2.14
Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology (1992) 1.89
Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Res (1994) 1.89
A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J Virol (1998) 1.88
Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays. J Clin Microbiol (1992) 1.87
Experimental measles. I. Pathogenesis in the normal and the immunized host. Virology (1997) 1.83
Use of antibodies directed against synthetic peptides for identifying cDNA clones, establishing reading frames, and deducing the gene order of measles virus. J Virol (1985) 1.75
Matrix genes of measles virus and canine distemper virus: cloning, nucleotide sequences, and deduced amino acid sequences. J Virol (1986) 1.74
Clinical isolates of measles virus use CD46 as a cellular receptor. J Virol (2000) 1.72
Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J Clin Microbiol (1991) 1.68
Molecular epidemiology of measles virus: identification of pathways of transmission and implications for measles elimination. J Infect Dis (1996) 1.66
Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J Infect Dis (1999) 1.62
Sequence analysis of the 17-kilodalton-antigen gene from Rickettsia rickettsii. J Bacteriol (1987) 1.61
Sequence homology within the morbilliviruses. J Virol (1985) 1.56
Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. J Infect Dis (1997) 1.56
Accumulated measles virus mutations in a case of subacute sclerosing panencephalitis: interrupted matrix protein reading frame and transcription alteration. Virology (1986) 1.49
Molecular characterization of the polymerase gene and genomic termini of Nipah virus. Virology (2001) 1.47
New genetic group of measles virus isolated in the People's Republic of China. Virus Res (1998) 1.42
Molecular epidemiology of measles virus. Curr Top Microbiol Immunol (2009) 1.41
Spontaneous mutation rate of measles virus: direct estimation based on mutations conferring monoclonal antibody resistance. J Virol (1999) 1.38
Genetic analysis of measles viruses isolated in the United States, 1995-1996. J Infect Dis (1998) 1.36
Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection. J Med Virol (1993) 1.31
Evolution of the nucleoprotein and matrix genes of wild-type strains of measles virus isolated from recent epidemics. Virology (1994) 1.31
Nosocomial transmission of measles: an updated review. Vaccine (2012) 1.23
Localization of monoclonal antibody epitopes and functional domains in the hemagglutinin protein of measles virus. J Virol (1995) 1.19
Detection of measles virus RNA in urine specimens from vaccine recipients. J Clin Microbiol (1995) 1.19
Genetic characterization of contemporary wild-type measles viruses from Vietnam and the People's Republic of China: identification of two genotypes within clade H. Virus Res (2001) 1.18
New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries. Health Policy Plan (2012) 1.14
Timing of development of measles-specific immunoglobulin M and G after primary measles vaccination. Clin Diagn Lab Immunol (1999) 1.14
Measles eradication: is it in our future? Am J Public Health (2000) 1.12
Positive identification of a measles virus cDNA clone encoding a region of the phosphoprotein. J Virol (1984) 1.11
Measles virus strain variations. Curr Top Microbiol Immunol (1995) 1.08
The diversity of measles virus in the United Kingdom, 1992-1995. J Gen Virol (1997) 1.08
Nonclassic measles infections in an immune population exposed to measles during a college bus trip. J Med Virol (1998) 1.08
Human cellular immune response to measles virus polypeptides. J Virol (1984) 1.07
Purification of measles virus with preservation of infectivity and antigenicity. J Gen Virol (1979) 1.06
Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature. Clin Infect Dis (1993) 1.05
Antigenic analysis of current wild type and vaccine strains of measles virus. J Infect Dis (1994) 1.05
Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination. JAMA (1996) 1.05
Immune reactivity of the purified hemagglutinin of measles virus. Infect Immun (1981) 1.04
Impact of measles elimination activities on immunization services and health systems: findings from six countries. J Infect Dis (2011) 1.04
Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray. Clin Exp Immunol (2014) 1.03
Measles inclusion-body encephalitis caused by the vaccine strain of measles virus. Clin Infect Dis (1999) 1.03
Disseminated measles infection after vaccination in a child with a congenital immunodeficiency. J Pediatr (1994) 1.02
Comparative detection of measles and rubella IgM and IgG derived from filter paper blood and serum samples. J Med Virol (2001) 1.02
Measles antibody in vaccinated human immunodeficiency virus type 1-infected children. Pediatrics (1996) 1.02
Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006. J Med Virol (2009) 1.01
Lack of evidence of endogenous avian leukosis virus and endogenous avian retrovirus transmission to measles, mumps, and rubella vaccine recipients. Emerg Infect Dis (2001) 1.00
Monospecific antibody to the haemagglutinin of measles virus. J Gen Virol (1980) 1.00
Biosynthesis of measles virus hemagglutinin in persistently infected cells. Arch Virol (1983) 0.99
Antibodies to the structural polypeptides of measles virus following acute infection and in SSPE. Clin Exp Immunol (1980) 0.98
Decline of measles-specific immunoglobulin M antibodies after primary measles, mumps, and rubella vaccination. Clin Diagn Lab Immunol (1998) 0.96
An evaluation of measles revaccination among school-entry-aged children. Pediatrics (1996) 0.94
Rabies diagnostic reagents prepared from a rabies N gene recombinant expressed in baculovirus. J Clin Microbiol (1990) 0.93
Characterization of cloned measles virus mRNAs by in vitro transcription, translation, and immunoprecipitation. Intervirology (1987) 0.92
Protection of mice with vaccinia virus recombinants that express the rabies nucleoprotein. Virology (1991) 0.92
Raccoon poxvirus recombinants expressing the rabies virus nucleoprotein protect mice against lethal rabies virus infection. J Virol (1991) 0.92
Recognition of intracellular measles virus antigens by HLA class II restricted measles virus-specific cytotoxic T lymphocytes. Ann N Y Acad Sci (1988) 0.91
Idiotypes and biological activity of murine monoclonal antibodies against the hemagglutinin of measles virus. Infect Immun (1981) 0.90
Cloned measles virus-specific T lymphocytes from a twin with multiple sclerosis. Proc Natl Acad Sci U S A (1983) 0.90
Monitoring progress toward measles elimination by genetic diversity analysis of measles viruses in China 2009-2010. Clin Microbiol Infect (2014) 0.90
Use of synthetic peptides to identify measles nucleoprotein T-cell epitopes in vaccinated and naturally infected humans. Virology (1997) 0.87
Induction of intercellular adhesion molecule 1 gene expression by measles virus in human umbilical vein endothelial cells. J Med Virol (1999) 0.87
Comparison of L proteins of vaccine and wild-type measles viruses. J Gen Virol (1999) 0.86
Genetic variability and mRNA editing frequencies of the phosphoprotein genes of wild-type measles viruses. Virus Res (2008) 0.86
Restriction of fusion protein mRNA as a mechanism of measles virus persistence. Virology (1994) 0.86
Generation of defective interfering particles by two vaccine strains of measles virus. Virology (1996) 0.86
Cloning and characterization of DNA complementary to the canine distemper virus mRNA encoding matrix, phosphoprotein, and nucleocapsid protein. J Virol (1985) 0.84
Assessment of neonatal tetanus elimination in an African setting by lot quality assurance cluster sampling (LQA-CS). Epidemiol Infect (2003) 0.83
Antibody-mediated modification of encephalitis induced by hamster neurotropic measles virus. J Infect Dis (1983) 0.83
Impact of nationwide measles vaccination campaign among children aged 9 months to 14 years, Zimbabwe, 1998-2001. J Infect Dis (2003) 0.83
Measles vaccine effectiveness and duration of vaccine-induced immunity in the absence of boosting from exposure to measles virus. Pediatr Infect Dis J (1996) 0.83
Hypermutation of the phosphoprotein and altered mRNA editing in the hamster neurotropic strain of measles virus. Virology (1995) 0.82
Strain-specific differences in LFA-1 induction on measles virus-infected monocytes and adhesion and viral transmission to endothelial cells. J Virol (1998) 0.81
Nucleotide sequence of the P34 gene from Rickettsia rickettsii. Nucleic Acids Res (1990) 0.80
Infectious disease surveillance during emergency relief to Bhutanese refugees in Nepal. JAMA (1994) 0.80
Genomic characterization of wild-type measles viruses that circulated in different states in Brazil during the 1997 measles epidemic. J Med Virol (2001) 0.80
Induction of cytokine mRNA in peripheral blood mononuclear cells of infants after the first dose of measles vaccine. Vaccine (2001) 0.80
Measles immunity in HIV-infected children. Pediatr AIDS HIV Infect (1994) 0.79
Hepatitis B and delta vaccination program in the western Amazon region of Brazil. Prog Clin Biol Res (1991) 0.79
Comparative detection of measles-specific IgM in oral fluid and serum from children by an antibody-capture IgM EIA. J Infect Dis (1996) 0.78
Management of a measles outbreak among Old World nonhuman primates. Lab Anim Sci (1999) 0.77
The effect of timing of sample collection on the detection of measles-specific IgM in serum and oral fluid samples after primary measles vaccination. Epidemiol Infect (1999) 0.77
Population biology, evolution, and immunology of vaccination and vaccination programs. Am J Med Sci (1998) 0.76
Metabolic characteristics of cells infected with a herpesvirus of turkeys. J Natl Cancer Inst (1975) 0.75
Missed opportunities for vaccination in Chitungwiza, Zimbabwe 1995: a service deficiency which can easily be eliminated. Cent Afr J Med (1996) 0.75
Maternal immunity to measles and infant immunity at less than twelve months of age relative to maternal place of birth. J Pediatr (1994) 0.75
Genetic and antigenic characterisation of the haemagglutinin protein of measles virus strains recently circulating in the UK. Virus Res (1998) 0.75
Progress towards polio eradication in Zimbabwe. Cent Afr J Med (1999) 0.75
Country overview--a report of the international evaluation of the immunization programme in India. Indian Pediatr (1993) 0.75